Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma

Abstract

BackgroundThe CC chemokine receptor 9 (CCR9) plays an important role in tumorigenesis and metastasis in various cancers. Our previous studies have shown the aberrant expression of CCR9 in non-small cell lung cancer (NSCLC) cell lines, revealing that the CCR9-CCL25 axis modulates cell migration and invasion, and supports cancer cell survival by inhibiting apoptosis in vitro and in vivo. In the present study, we aimed to evaluate the expression and possible prognostic role of CCR9 in lung adenocarcinoma.MethodsImmunohistochemical analysis of CCR9 expression was performed on 144 lung adenocarcinoma tissues and 30 adjacent normal lung parenchymal tissues. We assessed the correlation of CCR9 expression with clinicopathological characteristics and the prognosis of lung adenocarcinoma.ResultsThe expression of CCR9 was increased in lung adenocarcinoma tissue compared with normal lung tissue. Moreover, such an expression was positively correlated with tumor size (p = 0.032), lymph node metastasis (p = 0.002) and advanced TNM stage (p = 0.012). In addition, the patients with negative CCR9 expression exhibited a higher overall survival (OS) compared with those with positive CCR9 expression. Multivariate analysis showed that the CCR9 expression was an independent prognostic factor for the OS of patients with lung adenocarcinoma.ConclusionsWe, for the first time, reported that CCR9 could be beneficial in predicting lymph node metastasis, and it might act as a novel prognostic biomarker for lung adenocarcinoma.

Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma

“…In conclusion, disruption of the CCR9/ CCL25 axis in tumor bearers may affect homeostasis of the common lymphoid system and compromise the delicate balance between gut and systemic immunity (45). Nonetheless, several observations point to a cellautonomous role of CCR9/CCL25 in cancer cell migration, invasion, and metastatic dissemination as well as in PI3Kdependent resistance to chemotherapy (46)(47)(48)(49)(50)(51). Enforced CCR9 expression on colorectal cancer cells dictated their niching in mouse intestines after xenografting, whereas CCL25 blockade enhanced liver metastases (52).…”

The role of chemokine receptor 9/chemokine ligand 25 signaling: From immune cells to cancer cells (Review)

“…Similarly, CCR9 could be beneficial in predicting lymph node metastasis and prognosis in lung adenocarcinoma ( 67 ). Adenocarcinoma cells revealed a higher migratory and invasive potential in response to CCL25, compared with squamous cell carcinoma cells, which had lower expression of CCR9 and CCL25 ( 68 ).…”

Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction

“…Chemokine receptors are seven transmembrane-spanning heterotrimeric G protein-coupled receptors that are mainly expressed on both immune cells and other nonimmune cells, such as tumor cells and endothelial cells 8 . Chemokines and chemokine receptors interact with each other to stimulate the migration of lymphocytes, monocytes, neutrophils, endothelial cells and mesenchymal stem cells as well as tumor progression, angiogenesis and metastasis 9 .…”